MedPath

Sodium Nitrite

These highlights do not include all the information needed to use Sodium Nitrite Injection safely and effectively. See full prescribing information for Sodium Nitrite Injection. Sodium Nitrite Injection, USPInitial U.S. Approval: 2011

Approved
Approval ID

52f01c6e-172a-47a9-98a6-9eab7651a032

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 14, 2022

Manufacturers
FDA

Hope Pharmaceuticals

DUNS: 015227945

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Nitrite

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60267-311
Application NumberNDA203922
Product Classification
M
Marketing Category
C73594
G
Generic Name
Sodium Nitrite
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 20, 2021
FDA Product Classification

INGREDIENTS (3)

Sodium NitriteActive
Quantity: 30 mg in 1 mL
Code: M0KG633D4F
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT
NitrogenInactive
Code: N762921K75
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Nitrite - FDA Drug Approval Details